$1.65 Earnings Per Share Expected for CME Group Inc (NASDAQ:CME) This Quarter

Wall Street brokerages expect CME Group Inc (NASDAQ:CME) to announce $1.65 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for CME Group’s earnings, with the lowest EPS estimate coming in at $1.53 and the highest estimate coming in at $1.80. CME Group reported earnings per share of $1.77 during the same quarter last year, which suggests a negative year over year growth rate of 6.8%. The company is scheduled to report its next quarterly earnings results on Thursday, February 13th.

On average, analysts expect that CME Group will report full year earnings of $6.90 per share for the current fiscal year, with EPS estimates ranging from $6.78 to $7.08. For the next year, analysts anticipate that the company will post earnings of $7.44 per share, with EPS estimates ranging from $7.16 to $7.84. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow CME Group.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.15. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business’s revenue for the quarter was up 41.3% compared to the same quarter last year. During the same period last year, the business posted $1.45 earnings per share.

A number of equities research analysts recently weighed in on CME shares. Wells Fargo & Co upped their target price on shares of CME Group from $200.00 to $205.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Oppenheimer started coverage on shares of CME Group in a research report on Monday, September 16th. They issued an “outperform” rating and a $234.00 price objective for the company. UBS Group reduced their target price on shares of CME Group from $220.00 to $218.00 and set a “neutral” rating for the company in a research report on Thursday, October 31st. Citigroup increased their target price on shares of CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a research report on Monday, October 21st. Finally, ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $203.36.

In other news, Director Daniel R. Glickman sold 500 shares of the company’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $216.01, for a total value of $108,005.00. Following the transaction, the director now directly owns 14,593 shares in the company, valued at $3,152,233.93. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Sean Tully sold 7,200 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the transaction, the insider now owns 19,923 shares in the company, valued at $4,445,418.99. The disclosure for this sale can be found here. Insiders sold 13,936 shares of company stock worth $3,060,714 in the last three months. Insiders own 1.20% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of CME. Vanguard Group Inc. grew its holdings in shares of CME Group by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 27,992,457 shares of the financial services provider’s stock valued at $5,433,616,000 after acquiring an additional 328,318 shares in the last quarter. Edgewood Management LLC grew its stake in CME Group by 1.5% in the 2nd quarter. Edgewood Management LLC now owns 7,530,705 shares of the financial services provider’s stock valued at $1,461,785,000 after acquiring an additional 112,624 shares during the period. Bank of New York Mellon Corp grew its stake in CME Group by 0.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,478,698 shares of the financial services provider’s stock valued at $675,250,000 after acquiring an additional 21,717 shares during the period. Nuveen Asset Management LLC grew its stake in CME Group by 18,355.3% in the 2nd quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock valued at $628,631,000 after acquiring an additional 3,220,982 shares during the period. Finally, Fiera Capital Corp grew its stake in CME Group by 17.0% in the 2nd quarter. Fiera Capital Corp now owns 2,960,477 shares of the financial services provider’s stock valued at $574,658,000 after acquiring an additional 429,235 shares during the period. Hedge funds and other institutional investors own 84.77% of the company’s stock.

CME stock traded down $1.85 during mid-day trading on Thursday, hitting $204.20. 1,177,700 shares of the company were exchanged, compared to its average volume of 1,350,785. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.14. CME Group has a 1-year low of $161.05 and a 1-year high of $224.91. The stock has a market capitalization of $73.84 billion, a PE ratio of 29.94, a price-to-earnings-growth ratio of 4.05 and a beta of 0.18. The business has a 50 day simple moving average of $207.24 and a 200-day simple moving average of $202.35.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Tuesday, December 10th will be given a $0.75 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.47%. CME Group’s payout ratio is currently 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: Investing in Blue-Chip Stocks

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.